Las Vegas, NV -- (SBWIRE) -- 07/20/2013 -- Value Stock Pick is a leading Investment Newsletter. Our Research Team conducts research on different stocks, doing their due diligence to provide a detailed report, including both technical and fundamental analysis, on NYSE, NASDAQ, AMEX, OTCBB and Pink Sheet Stocks. Let’s have a brief look at: FREDDIE MAC PFD Z (OTCBB:FMCKJ), Sigma Labs Inc (OTCMKTS:SGLB), GULF COAST ULTRA (OTCMKTS:GULTU), International Stem Cell Corp (OTCMKTS:ISCO)
FREDDIE MAC PFD Z (OTCBB:FMCKJ) declined -1.20%, trading on 329,522 shares to end the trade at $4.94. The stock changed hands in a range of $4.88 to $5.06, bringing its market capitalization at about $1.20 billion. If we look at its trading history of past 52 weeks, the share price suffered low of $0.42 and was moved to maximum level of $7.24.
Will FMCKJ Bounce Back After yesterday’s Sharp Sell off? Find Out Here
Sigma Labs Inc (OTCMKTS:SGLB) declined -3.51% to complete the trading session at $0.110 with a total volume of 11.95 million shares. The stock, on average, trades on a volume of 3.87 million shares. It floated in a range of $0.10 to $0.14 during last trading session with a beta value of 6.44. Its market capitalization now moved to about $47.04 million. In the past 52 weeks, the share price has not declined below $0.01and above $0.14. Sigma Labs, Inc. engages in the development and commercialization of manufacturing and materials technologies, and R&D solutions. It also focuses on commercializing technologies and products in various industry sectors
Is it the Right to Grab SGLB after the Recent Slump? Get Free Trend Analysis Here
GULF COAST ULTRA (OTCMKTS:GULTU) added 0.96% and was in a range of $2.06-$2.13 before closing at $2.10. The stock completed the day with a total volume of 663,839 shares versus an average volume of 2.05 million shares. The share price hit its 52-week low of $1.75 and $2.50 was the best price.
Why Should Investors Buy GULTU After The Recent Gain? Just Go Here and Find Out
International Stem Cell Corp (OTCMKTS:ISCO) declined -40% yesterday, bringing its market capitalization around $16.85 million. The share price after opening at $0.16 made a high of $0.17 and hovered above $0.14 to end the day at $0.150. The total number of shares changed hands during the session was 5.55 million shares as compared to average trading volume of 108,043 shares. International Stem Cell Corporation, a developmental stage biotechnology company, engages in the development and commercialization of therapeutic, biomedical, and cosmeceutical products in the United States and internationally. Its products are based on human parthenogenetic stem cells, a proprietary type of pluripotent stem cells.
Will ISCO Reach the Bottom after Yesterday’s Correction? Find Out Here
About Value Stock Pick
Value Stock Pick is a leading Investment Newsletter. Our Research Team conducts research on different stocks, doing their due diligence to provide a detailed report, including both technical and fundamental analysis, on NYSE, NASDAQ, AMEX, OTCBB and Pink Sheet Stocks.
PLEASE NOTE WELL: The employees of ValueStockPick.com are not registered as Investment Advisors in any jurisdiction whatsoever. Never invest in any stock featured on our site, Press releases or emails unless you can afford to lose your entire investment. Investing in “penny stocks” is highly speculative.
Please Read Our Full Disclaimer at http://www.valuestockpick.com/disclaimer/
Copyright © 2005-2013 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-593-5640 (International)